Concepedia

Riccardo Marconcini

RM

Statistics

Publications

36

Citations

3.1K

H-Index

23

Active since

2013

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

European Institute of Oncology

Azienda Ospedaliera Universitaria Pisana

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Sapienza University of Rome

Riccardo Marconcini is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

2013–2024

36

Publications

36

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 415 citations · Full text

, , +16

Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma

Stefan Diem, Benjamin Kasenda, Lavinia Spain et al. · British Journal of Cancer · 2016 · 308 citations · Full text

, , +17

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 264 citations · Full text

, , +14

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC

Marzia Del Re, Riccardo Marconcini, G. Pasquini et al. · British Journal of Cancer · 2018 · 250 citations · Full text

, , +17

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini et al. · The Oncologist · 2019 · 221 citations · Full text

, , +17

1–5 of 36